⌘K

Login Start Free

Home/Filings/4/0001250853-18-000044

4//SEC Filing

Townsend Raymond 4

Accession 0001250853-18-000044

CIK 0001561743other

View on SEC.gov Company Profile

Filed

Mar 18, 8:00 PM ET

Accepted

Mar 19, 6:41 PM ET

Size

20.6 KB

Accession

0001250853-18-000044

Insider Transaction Report

Form 4

Period: 2018-03-15

Kindred Biosciences, Inc.KIN

Townsend Raymond

Director

Transactions

Sale
Common Stock
2018-03-15$9.45/sh−1,760$16,632→ 23,297 total
Exercise/Conversion
Stock Option (right to buy)
2018-03-16−910→ 20,470 total
Exercise: $3.45Exp: 2026-01-08→ Common Stock (910 underlying)
Exercise/Conversion
Common Stock
2018-03-15$3.45/sh+1,760$6,072→ 25,057 total
Exercise/Conversion
Common Stock
2018-03-16$3.45/sh+1,578$5,444→ 27,928 total
Exercise/Conversion
Common Stock
2018-03-15$3.45/sh+3,053$10,533→ 26,350 total
Exercise/Conversion
Stock Option (right to buy)
2018-03-16−1,578→ 18,892 total
Exercise: $3.45Exp: 2026-01-08→ Common Stock (1,578 underlying)
Exercise/Conversion
Common Stock
2018-03-16$3.45/sh+910$3,140→ 27,260 total
Sale
Common Stock
2018-03-16$9.45/sh−910$8,600→ 26,350 total
Exercise/Conversion
Stock Option (right to buy)
2018-03-15−3,053→ 21,380 total
Exercise: $3.45Exp: 2026-01-08→ Common Stock (3,053 underlying)
Exercise/Conversion
Stock Option (right to buy)
2018-03-15−1,760→ 24,433 total
Exercise: $3.45Exp: 2026-01-08→ Common Stock (1,760 underlying)

Footnotes (2)

[F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 30, 2017.
[F2]The option vested 25% quarterly following January 8, 2016, the date of grant.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

Kindred Biosciences, Inc.

CIK 0001561743

Entity typeother

Related Parties

1

filerCIK 0001593867

Filing Metadata

Form type: 4
Filed: Mar 18, 8:00 PM ET
Accepted: Mar 19, 6:41 PM ET
Size: 20.6 KB

View on SEC.gov